COR THERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 7129
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 6249
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 1205

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6630451 Benzimidazolone peptidometics as thrombin receptor antagonistJun 22, 00Oct 07, 03[C07K]
6365617 Indole and indazole urea-peptoids as thrombin receptor antagonistsJun 26, 00Apr 02, 02[A61K, C07D, A61P]
6291469 Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregationOct 05, 98Sep 18, 01[A61K, C07D]
6197541 Recombinant thrombin receptors and assays using themFeb 17, 93Mar 06, 01[C12N, G01N, C07K]
6022861 Ketoheterocyclic inhibitors of factor XaJun 07, 95Feb 08, 00[A61K]
5872218 Human platelet-derived growth factor receptor extracellular domain antibodiesJun 02, 95Feb 16, 99[C07K]
5856448 Antibodies specifically reactive with thrombin receptor and its componentsJun 07, 95Jan 05, 99[C12P, C07K]
5705606 Peptides derived from GPIIIaDec 21, 93Jan 06, 98[A61K, C07K]
5686572 Domains of extracellular region of human platelet derived growth factor receptor polypeptidesDec 15, 93Nov 11, 97[C07K]
5674892 Method and compositions for inhibiting protein kinasesJun 05, 95Oct 07, 97[A61K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2004/0072,757 Agents affecting thrombosis and hemostasisAbandonedNov 13, 03Apr 15, 04[A61K]
2003/0228,307 Inhibitory immunoglobulin polypeptides to human PDGF beta receptorAbandonedMay 16, 03Dec 11, 03[A61K, C07K]
6613930 Methods for producing 3-cyano-and 4-cyano- benzoic acid derivative compoundsExpiredDec 13, 00Sep 02, 03[C07C]
2003/0135,036 Platelet glycoprotein v gene and usesAbandonedAug 06, 02Jul 17, 03[A61K, C12Q, C12P, C12N, C07K]
6245743 Inhibitors of factor XaExpiredMay 15, 98Jun 12, 01[A61K, C07K]
6245809 Integrin antagonistsExpiredJun 08, 99Jun 12, 01[A61K, C07C]
6211154 Ketoheterocyclic inhibitors of factor XaExpiredJun 07, 95Apr 03, 01[A61K, C07K]
6197748 Ketoheterocyclic inhibitors of factor XaExpiredMay 15, 98Mar 06, 01[A61K, C07K]
6124101 Recombinant thrombin receptor and related pharmaceuticalsExpiredJun 07, 95Sep 26, 00[G01H]
6069130 Ketoheterocyclic inhibitors of factor XaExpiredJun 07, 95May 30, 00[A61K, C07K]
6046169 Inhibitors of factor XAExpiredJun 07, 95Apr 04, 00[A61K, C07K]
6024936 Antibody-based method of localizing activated thrombin receptorsExpiredJun 07, 95Feb 15, 00[A61K, G01N, C07K]
5919765 Inhibitors of factor XAExpiredJun 07, 95Jul 06, 99[A61K, C07K]
5759994 Recombinant thrombin receptor and related pharmaceuticalsExpiredJun 07, 95Jun 02, 98[A61K, C07K]
5728726 Method and compositions for inhibiting protein kinasesExpiredJun 05, 95Mar 17, 98[A61K]
5721214 Inhibitors of factor XaExpiredJun 07, 95Feb 24, 98[A61K, C07K]
5688768 Recombinant thrombin receptor and related pharmaceuticalsExpiredNov 07, 91Nov 18, 97[A61K, C07K]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.